Sp388
PERIANAL AND INTRAABDOMINAL FISTULAS IN CROHN’S: ROLE OF MEDICATIONS, DIET, STEM CELLS, AND SURGERY
Date
May 19, 2024
Presenter
Cleveland Clinic
Tracks
Related Products
IBD Controlled Trials II
SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…
BOWEL URGENCY OUTCOMES ARE ASSOCIATED WITH IMPROVEMENT IN FATIGUE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A POOLED ANALYSIS OF LUCENT-1 AND LUCENT-2 PHASE 3 TRIALS
BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
SESSILE SERRATED POLYP DETECTION RATE IN ASYMPTOMATIC AVERAGE RISK INDIVIDUALS WITH POSITIVE FECAL IMMUNOCHEMICAL AND MULTITARGET STOOL DNA TEST: A SYSTEMATIC REVIEW AND META-ANALYSIS
INTRODUCTION: The ultimate goal of colorectal cancer (CRC) screening is to prevent CRC by detecting advanced adenomas that potentially progress to CRC…
